CelestineWanjallaMDPhD
Internal Medicine • Nashville, TNHIV/AIDS Medicine, Infectious Disease
Assistant Professor
Dr. Wanjalla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-936-2000Fax+1 615-936-0605
Summary
- I am a board certified physician scientist in the Division of Infectious Diseases at Vanderbilt University Medical Center. I care for patients living with HIV at the Comprehensive Care Clinic and on the Infectious Disease consult service. The goal of my research is to understand the role of virus-specific immune cells in atherosclerotic cardiovascular disease pathogenesis in persons living with HIV. My long term goal is to define innate and adaptive immune markers that can improve the risk stratification of CVD in persons with HIV, identify novel therapeutic targets and improve clinical outcomes.
Education & Training
Vanderbilt University Medical CenterResidency, Internal Medicine, 2013 - 2016
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2013
Certifications & Licensure
TN State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 5 citationsMean Coronary Cross-Sectional Area as a Measure of Arterial Remodeling Using Noncontrast CT Imaging in Persons With HIV.Ayoda T Werede, James G Terry, Sangeeta Nair, Tecla M Temu, Bryan E Shepherd
Journal of the American Heart Association. 2022-12-06 - 4 citationsChanges in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIV.Samuel S Bailin, Jonathan A Kropski, Rama D Gangula, LaToya Hannah, Joshua D Simmons
Frontiers in Immunology. 2023-01-01 - 7 citationsCD4T cells expressing CX3CR1, GPR56, with variable CD57 are associated with cardiometabolic diseases in persons with HIV.Celestine N Wanjalla, Curtis L Gabriel, Hubaida Fuseini, Samuel S Bailin, Mona Mashayekhi
Frontiers in Immunology. 2023-01-01
Journal Articles
- Adipose Tissue in Persons With HIV Is Enriched for CD4+ T Effector Memory and T Effector Memory RA+ Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co...Celestine N. Wanjalla, Wyatt J. McDonnell, Louise Barnett, Joshua D. Simmons, Briana D. Furch, Morgan C. Lima, Beverly O. Woodward, Run Fan, Ye Fei, Paxton G. Baker, R..., Frontiers In Immunology
Press Mentions
Clue to Salt-Sensitive Blood Pressure FoundOctober 21st, 2024- Research Raises Hope for Treating Potentially Lethal Blood ConditionJune 4th, 2024
- Wanjalla Honored by Doris Duke FoundationAugust 12th, 2021
Professional Memberships
- Member
Other Languages
- Swahili
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
